Published by
@ShahidNShah
@ShahidNShah
Creative Diagnostics Announces the Launch of SARS-CoV-2 ADE Assay
Creative Diagnostics, a global leader in offering raw materials, antibodies, and reagents for the bio-technology industry, announced the launch of SARS-CoV-2 ADE Assay to support laboratory scientists for SARS-CoV-2 vaccine research. It is noted that these new ADE assays are intended for research and laboratory use only, not for diagnostic, therapeutic, drug, household or other applications.
Continue reading at rivercountry.newschannelnebraska.com
Make faster decisions with community advice
- AMA survey: Doctors more optimistic about digital health tools
- Clearwater and CynergisTek Complete Merger, Bringing Together Cybersecurity, Privacy, and Compliance Leaders
- ENT Partners Joins Lynx MD in Building the World’s Largest Repository of ENT Data
- Honeywell To Collaborate With Leading Health Providers To Advance Digitalization Of Healthcare Globally
- Natural language processing is boosting behavioral healthcare
Next Article
-
ENT Partners Joins Lynx MD in Building the World’s Largest Repository of ENT Data
Using the cloud-based Lynx MD platform, ENT Partners can securely, and with privacy controls in place, share accumulated real-world health data with academics, pharmaceutical companies and MedTech …
Posted Sep 16, 2022 Patient Data Healthcare
